Medtech And US DoJ: EpiPen, Dermagraft Lead 2017 Payouts To Feds

US DoJ collected more than $1bn in penalties from device manufacturers this year, chiefly on false claims and manufacturing violations. Here is a roundup and sortable table of the payouts.

Symbol of law and justice

The US Department of Justice announced resolutions to nine medical-device related investigations this year, collecting more than a billion dollars in fines.

The largest single settlement involved a combination product that the government reimburses as a drug. In August, Mylan Pharmaceuticals...

Welcome to Medtech Insight

Create an account to read this article

More from Legal & IP

More from Policy & Regulation